Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
SAN FRANCISCO and SUZHOU, China, June 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major disease areas, announced that the first participant has been successfully dosed in a Phase 3 clinical trial (GLORY-OSA) of mazdutide,...
13th International Art of Giving Day Celebrated in 190 Countries
BHUBANESHWAR, India, May 19, 2026 /PRNewswire/ -- The 13th International Art of Giving Day, inspired by the vision of Dr. Achyuta Samanta, was celebrated this year across 190 countries spanning six continents. In addition, followers and well-wishers of the Art of Giving movement participated in the campaign at 50,000 locations internationally, including all 222 FIVB member nations, all...
ATOTO CB7 Pro 301% Funded–Head‑Unit AI Console for Wireless CarPlay/Android Auto and Camera‑Smart Driving
SHENZHEN, China, Jan. 23, 2026 /PRNewswire/ -- ATOTO shared an update on CB7 Pro, its Head-Unit AI Console. It's built on a simple philosophy: don't replace the factory screen—give it new capabilities. CB7 Pro plugs into the USB port used for wired CarPlay or wired Android Auto, upgrades the head unit to wireless CarPlay and wireless Android Auto, adds...
Masterpieces of the Pola Museum of Art: Western Painting – French Painting from Impressionism to the Early 20th Century
KANAGAWA, Japan, April 8, 2024 /PRNewswire/ -- This year, 2024, marks the 150 anniversary of the First Impressionist Exhibition, held in Paris in 1874. At the Pola Museum of Art (located in Hakone, Kanagawa Prefecture; director: Noguchi Hiroko), we are currently presenting Western Painting – French Painting from Impressionism to the Early 20th Century, an exhibition drawn from...
Tradewind Finance Provides USD 3.5 Million Credit Facility for Hong Kong Subsidiary of Leading German Shirt Company
MÖNCHENGLADBACH, Germany, Oct. 24, 2025 /PRNewswire/ -- International trade finance company Tradewind Finance today announced a USD 3.5 million factoring facility for a Hong Kong subsidiary of a leading family-owned and operated shirt brand based in Germany. The Hong Kong company is utilizing the facility to further improve cash flow and efficiently manage...
Journey Joins Starlab to Design the Commercial Space Station Experience
HOUSTON, July 29, 2025 /PRNewswire/ -- Starlab Space LLC announced a strategic partnership with Journey, a multidimensional experience agency, that will help shape the interior and experiential design of the next-generation commercial space station. Journey joins Hilton and Airbus in developing a station environment that elevates how astronauts live and work in...
WesTrac and Palantir Renew Australian Partnership for Five Years
WesTrac will continue to leverage Palantir Foundry and deploy across entire operations DENVER and PERTH, Australia, Aug. 4, 2023 /PRNewswire/ -- Palantir Technologies Inc. (Palantir, NYSE: PLTR) and WesTrac Pty Ltd, one of the world's largest Caterpillar® dealers and leading provider of heavy mobile equipment and aftermarket services to the Australian mining...
ZERO BREEZE Launches Mark 3: The Revolutionary Portable AC for Outdoors on Indiegogo
PLANO, Texas, Oct. 27, 2023 /PRNewswire/ -- , a leading innovator with a 7-year history in the outdoor portable cooling industry proudly announces the launch of its newest product, the Mark 3 AC. The campaign kicked off on October 25th and astonishingly surpassed its funding goal by 350% within the first 24 hours. ZERO...
J INTS BIO, Oral TKI ‘JIN-A04’, poster presentation of HER2 exon20 insertion mutation in NSCLC
SEOUL, South Korea, Feb. 7, 2023 /PRNewswire/ -- J INTS BIO announced that the preclinical results of "JIN-A04," a novel oral tyrosine kinase inhibitor (TKI) targeting HER2 Exon20 insertion mutation in NSCLC, will be presented at the upcoming 2023 American Cancer Research Association meeting in Orlando, U.S. from April 14 to 19. J INTS BIO CI HER2 Exon20...
Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody
MIDDLETOWN, Del., July 10, 2025 /PRNewswire/ -- Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial for a novel anti-TL1A antibody (HXN-1001). The phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HXN-1001 in healthy volunteers. HXN-1001 is a half-life extended next-generation anti-TL1A antibody...






